SMTL ID : 6jc2.1

Crystal structure of the Fab fragment of ipilimumab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

hetero-1-1-mer

Ligands

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: R.16, S.17 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.17 Salt bridges: A:R.16 SO4.2: 3 residues within 4Å: Chain A: R.87, A.88, E.89 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:A.88, A:E.89 SO4.3: 4 residues within 4Å: Chain A: F.27, T.28, Y.32, W.101 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.28, A:T.28, A:Y.32 SO4.4: 4 residues within 4Å: Chain B: P.60, D.61, R.62, R.78 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:D.61, B:R.62 Salt bridges: B:R.62, B:R.78

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lee, J.Y. et al., Crystal Structure of the Fab Fragment of an Anti-CTLA-4 Antibody, Ipilimumab, Used for Cancer Immunotherapy. Bull.Korean Chem.Soc. (2019)

Release Date

2019-09-11

Peptides

ipilimumab fab heavy chain: A
ipilimumab fab light chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

ipilimumab fab heavy chain

ipilimumab fab light chain

Related Entries With Identical Sequence